UA88769U - Method for preventing and treating benign breast dysplasia in patients with early miscarriage - Google Patents

Method for preventing and treating benign breast dysplasia in patients with early miscarriage

Info

Publication number
UA88769U
UA88769U UAU201313731U UAU201313731U UA88769U UA 88769 U UA88769 U UA 88769U UA U201313731 U UAU201313731 U UA U201313731U UA U201313731 U UAU201313731 U UA U201313731U UA 88769 U UA88769 U UA 88769U
Authority
UA
Ukraine
Prior art keywords
patients
preventing
benign breast
treating benign
breast dysplasia
Prior art date
Application number
UAU201313731U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Алла Григоріївна Корнацька
Ольга Дмитріївна Дубенко
Ірина Олександрівна Баранецька
Алла Єфремівна Дубчак
Original Assignee
Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України" filed Critical Державна Установа "Інститут Педіатрії, Акушерства І Гінекології Намн України"
Priority to UAU201313731U priority Critical patent/UA88769U/en
Publication of UA88769U publication Critical patent/UA88769U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The method for preventing and treating benign breast dysplasia in the patients with early miscarriage comprises the background therapy with the use of Serrata as complex enzyme drug and Tazalok as phytomammoprotector at the average therapeutic doses.
UAU201313731U 2013-11-26 2013-11-26 Method for preventing and treating benign breast dysplasia in patients with early miscarriage UA88769U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201313731U UA88769U (en) 2013-11-26 2013-11-26 Method for preventing and treating benign breast dysplasia in patients with early miscarriage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201313731U UA88769U (en) 2013-11-26 2013-11-26 Method for preventing and treating benign breast dysplasia in patients with early miscarriage

Publications (1)

Publication Number Publication Date
UA88769U true UA88769U (en) 2014-03-25

Family

ID=56267884

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201313731U UA88769U (en) 2013-11-26 2013-11-26 Method for preventing and treating benign breast dysplasia in patients with early miscarriage

Country Status (1)

Country Link
UA (1) UA88769U (en)

Similar Documents

Publication Publication Date Title
MX2017014338A (en) Targeted selection of patients for treatment with cortistatin derivatives.
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
MX2020004023A (en) Use of a pcsk9 inhibitor to treat hyperlipidemia.
CL2016000354A1 (en) Modulation of tumor immunity
MX2015010312A (en) Methods of treating melanoma.
MX2016002645A (en) Combination therapy for the treatment of glioblastoma.
HK1221178A1 (en) Cabozantinib dosage form and use in the treatment of cancer
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
MX2016008013A (en) Antibody drug conjugates (adcs) with kinesin spindel protein (ksp).
SG10201902074UA (en) Heterocyclic compounds and uses thereof
PH12014502048B1 (en) Treatment of cancer with tor kinase inhibitors
NZ716473A (en) Diagnosis and therapy of cancer involving cancer stem cells
MX2016010504A (en) Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy.
PH12015500246A1 (en) Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor
MX2015011899A (en) Methods of treating cancer and preventing cancer drug resistance.
PH12014502029A1 (en) Treatment of cancer with tor kinase inhibitors
PH12014502046B1 (en) Treatment of cancer with tor kinase inhibitors
EA201591987A1 (en) TREATMENT OF MALIGNANT TUMOR DIHYDROPYRAZINOPIRASINS
MX2015010791A (en) Methods of treating cancer and preventing drug resistance.
MX2017015896A (en) Anticancer agent.
MX360189B (en) Combination therapy for the treatment of glioblastoma.
MX2015014599A (en) Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer.
IL245738A0 (en) Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases
EP2969008A4 (en) Medicament for treatment of cancer, cardiovascular diseases and inflammation
NZ704554A (en) Combination therapy of a smac mimetic and gm-csf